Thursday, May 29, 2014

Official: Texas Can Keep Lethal Drug Source Secret

Texas' prison system doesn't have to reveal where it gets its execution drugs, the state attorney general said Thursday, marking a reversal by the state's top prosecutor on an issue being challenged in several death penalty states.
Attorney General Greg Abbott, the Republican nominee for governor in the nation's busiest death penalty state, had rebuffed three similar attempts by the Texas Department of Criminal Justice since 2010. His decision can be appealed to the courts.
The department argues that the compounding pharmacy providing the drug should remain secret in order to protect it from threats of violence. Lawyers for death row inmates say they need its name to verify the drugs' potency and protect inmates from cruel and unusual punishment.
Similar legal fights are ongoing in other death penalty states, including Oklahoma and Missouri, but courts — including the U.S. Supreme Court — have yet to halt an execution based on a state's refusal to reveal its drug supplier. The secrecy argument also was used ahead of a bungled execution last month in Oklahoma, though that inmate's faulty veins, not the execution drug, were cited as the likely culprit.
The issue has put Abbott in a thorny position during an election year in Texas, where the death penalty is like gun rights: Candidates don't get in the way of either. Holding firm would please death penalty opponents, who prison officials say want to target drug suppliers with protests and threats; reversing course goes against his vows of government transparency.
continue to read here

Pharmagen Appoints Additional Members to its Board of Directors - KOAM TV 7

Pharmagen Appoints Additional Members to its Board of Directors - KOAM TV 7

FDA Powerpoint on cGMP in the USA

Powerpoint Presention from FDA Dr. Craig A. Lewis - Mitigating Pain in Livestock: What Options are Available

Dr. Craig A. Lewis - Mitigating Pain in Livestock: What ...


22 hours ago - ... Compounded Animal Drugs • If compounded from approved drugs (as starting ingredients) MAY be legal under ELU regulations • If compounded from bulk ...
Dr. Craig A. Lewis - Mitigating Pain in Livestock: What Options are Available



 

FDA’s Final Guidance on Expedited Drug Approvals: Fueling Innovation and Helping Patients

      Posted on May 29, 2014 by FDA Voice By: Janet Woodcock, M.D. - See more at: http://blogs.fda.gov/fdavoice/index.php/2014/05/fdas-final-guidance-on-expedited-drug-approvals-fueling-innovation-and-helping-patients/?source=govdelivery&utm_medium=email&utm_source=govdelivery#sthash.vE8j5Pph.dpuf

Hawaii Board of Pharmacy Meeting Minutes and Laws and Rules Committee Meeting Minutes for April 17, 2014

FDA Final Rule; Administrative Detention of Drugs Intended for Human or Animal Use

May 28, 2014 U.S. District Court Agrees With PhRMA, Vacates HRSA 340B Orphan Drug Rule

By Jay W. Cormier & Alan M. Kirschenbaum

Sixth Question of the Day: Is it a huge conflict of interest and ethical violation for a state board of pharmacy inspector to serve on the board of director for a state pharmacy association? If not, why not?


NABP FDA Detains Hundreds of Packages Containing Illegal Prescription Drugs Bound for US Consumers

 

Topics: Counterfeit drugs, Buying medicine online, and Fda
As part of the seventh annual International Internet Week of Action (IIWA), FDA and Customs and Border Protection detained and seized 583 packages of illegal prescription drugs at mailing facilities in Los Angeles, New York, and Chicago. These medications were ordered through rogue online drug sellers and websites. Preliminary findings show that certain drug products from abroad, including insulin, estrogen, bimatoprost, human chorionic gonadotropin, tramadol, tadalafil, and sildenafil citrate, were being shipped to United States consumers, notes an FDA press release. In addition to seizing the packages, FDA notified Internet service providers, domain name registrars, and related organizations that nearly 2,000 websites were selling products in violation of US law.
Known as Operation Pangea VII, the IIWA efforts brought together law enforcement, customs, and regulatory authorities from 111 countries. Worldwide, nearly 20,000 packages containing medications purportedly from Australia, the United Kingdom, New Zealand, and Canada were seized. In fact, these packages actually contained unapproved or suspected counterfeit medications from other countries, including China, Singapore, Taiwan, Mexico, Laos, and Malaysia.
IIWA is a collaborative effort involving FDA, INTERPOL, the World Customs Organization, Heads of Medicines Agencies Working Group of Enforcement Officers, and health and law enforcement agencies from the 111 participating countries.

quoted from here